Completed Discontinued Adverse Event Subject / AEs / SPECIAL/SUBGROUP / IND 67801 SDN / ITT / /
Country
United States / Canada / /
Event
FDA Phase / /
IndustryTerm
combination product / /
MedicalCondition
inflammatory and noninflammatory lesion counts / both inflammatory and non-inflammatory lesions / acne / Disease / cysts / erythema / inflammatory lesions / acne vulgaris / irritation / inflammatory and non-inflammatory lesion counts / inflammatory / /
Organization
U.S. Department of Health and Human Services / Translational Sciences Office / Division of Dermatology and Dental Products Clinical Team / Food and Drug Administration Center for Drug Evaluation / Research Office / Medical Division / /
Person
Dawn Williams Keywords / Matthew Guerra / Concurring Reviewers / Mohamed Alosh / Jill Lindstrom / Jane Liedtka / Source / /